Epidemiology & Biostats Flashcards
The specific morbidity rate is usually the number of:
a. Cases of a specific disease per 1,000,000 population
b. Deaths from a specific disease for a geographical area
c. Cases of a specific disease for a political area
d. Deaths from a specific disease per 100,000 population
e. Deaths from a specific disease per 100 cases of that disease
A. Morbidity relates to who gets sick from an illness. The denominator can be persons if the time period is specified, or person-years.
For the following 2x2 table for a diagnostic test, write out expressions for each term:
Disease + Disease -
Exposure + A B
Exposure - C D
a. Specificity
b. PPV
c. Total population
d. NPV
e. Prevalence
f. Sensitivity
a. Specificity: d/(b+d)
b. PPV: a/(a+b)
c. Total population: a+b+c+d
d. NPV: d/(c+d)
e. Prevalence: (a+c)/(a+b+c+d)
f. Sensitivity: a/(a+c)
The amount of health disorder existing in a population at one particular time, regardless of time of onset is known at the:
a. Prevalence
b. Incidence
c. Morbidity rate
d. Mortality rate
e. Attack rate
a. Prevalence
In prospective study or cohort type of epidemiologic study, two types of cohorts are selected. One of these is the exposed and the other is______; the measure of effect used in this study is _________
a. Cases; odds ratio
b. Susceptible; risk ratio
c. Affected ; relative risk
d. Non-exposed; incident rate ratio
e. Immune populations; odds ratio
D. Non-exposed; incident rate ratio
Textbook definition of a cohort study – following exposed and non-exposed over time to see who develops the disease.
The duration of a chronic disease process may complicate the epidemiologic study of its prevalence because of:
a. Loss of people or animals from the study by death from other causes
b. Changes in diagnostic techniques during the period of study
c. Changes in medical or veterinary care during the period of study
d. Decrease in interest level on the part of workers in the study
e. All of the above
E. All of the above
Pretty common sense, but in essence, if you want to know who is infected in a population, drop-out, changes in how a disease is diagnosed or treated can change your case definitions, your degree of ascertaiment of cases, etc.
When an epidemiologist is called to investigate a communicable disease emergency, the first thing he/she should try to determine is:
a. Possible sources of infection
b. Methods of transmission
c. Accuracy of the diagnosis
d. Methods of control
e. Extent of spread
C. Accuracy of the diagnosis
Making sure you know what disease you’re dealing with is the first step needed before asking any other questions
The occurrence in a community or region of cases of an illness in the human population clearly in excess of normal expectancy and derived from a common propagated source is an:
a. Epidemic
b. Endemic
c. Pandemic
d. Epizootic
e. Anthropozoonosis
A. Epidemic
This is the textbook definition of an epidemic.
Which of the following agent characteristics is most likely to be seen in a disease which occurs in epidemic proportions:
a. High infectivity
b. High pathogenicity
c. High virulence
d. Low antigenicity
e. Viability
A. High infectivity
For this question, I return to my definition of the R0, which is the average number of new cases of an infection caused by one typical infected individual, in a population consisting of susceptibles only. When R0>1, an epidemic occurs. R0 depends on the transmissibility or infectivity of the agent, the contact rate between hosts, and the time spent infectious. So if the infectivity of the agent increases, you’re more likely to have an epidemic.
In a study of alcohol and oral cancer the relative risk is 2.0 for men and 2.0 for women but 4.0 for both sexes combined. This suggests that:
a. There is confounding by sex in these data
b. There is confounding by some unknown or unmeasured factor in these data
c. There is evidence of effect modification in these data
d. The results have been adjusted for age and sex
e. The results are due to bias
A. There is confounding by sex in these data
General rule of thumb is that when you stratify by your variable of interest, it will be a confounder if both stratified effect estimates are similar and more than 10-15% different from the crude estimate.
A new treatment is developed that prevents death but does not produce recovery from disease. Which of the following will occur?
a. Prevalence will increase
b. Prevalence will decrease
c. Incidence will increase
d. Incidence will decrease
e. None of the above
A. Prevalence will increase
Think of prevalence as a water in a bucket. Prevalence increases when water (i.e., people with the disease) are added to the bucket. Prevalence decreases when there is a hole in the bucket and water is leaving the bucket (i.e., people are recoverying or dying and leaving the population). If more cases keep arriving but there are no departures from the population, the prevalence will increase.
In a country where a disease is endemic:
a) The number of affected animals tends to stay more or less constant over time
b) There have been at least 2 outbreaks of that disease in the past 5 years
c) The disease has persisted in that population for a long time
d) The vaccine for that disease is probably not used in a widespread manner
C. The disease has persisted in that population for a long time
The definition of an endemic is one that is regularly found among particular populations or in a certain area – so nothing about numbers or vaccination.
As a dairy practitioner, you read with great interest a recent paper describing a clinical trial testing a new drug to treat mastitis. This drug, called Masticate™, is touted as costing half the price and being easier to administer than most other therapies for mastitis. The paper tested this drug against the current standard of care, and the authors found no difference in cure rates. You decide to try it in your herd. Six months later, you find that Masticate™ is actually less effective than the drug you used before – whereas before, your cure rate was around 80%, now your cure rate is closer to 65%. Which of the following is the LEAST likely possible explanation for the discrepancies between your experience and the findings reported in the paper?
a) The sample size in the original paper was small, and therefore the study was underpowered to detect the difference you found.
b) The authors of the paper defined a successful cure differently than you did.
c) The animals enrolled in the study were primiparous cows only; your herd has a mix of different aged cows, and the results may therefore not have been generalizable to your herd.
d) The authors were not blinded to the treatment and therefore could have scored the cows receiving Masticate™ more generously.
e) The batch of drugs you used was defective.
E. The batch of drugs you used was defective.
All of the other options are very reasonable explanations of why two “studies” (i.e., the published paper and your experimental trial) would have found different answers.
A case control study compared the amount of daily coffee drank by patients with pancreatic cancer (cases) and patients with other GI conditions (controls). The study found a dose-response association between drinking coffee and pancreatic cancer that persisted when adjusting for cigarette smoking. What is the most likely explanation for the findings of the study? For bonus points, provide an explanation for why.
a) A true association – drinking coffee causes pancreatic cancer (yikes!)
b) Information bias
c) Selection bias
d) Confounding
- C. Selection bias
i.e., who gets into or stays in the study. This is a historical example so you may have heard of it, but you can come up with a likely explanation. Because controls often had GI issues such as esophagitis, ulcers, etc., they self-limited coffee consumption. Their coffee consumption was lower than that of the general population, so it appeared that cases drank more coffee. The controls were not representative of the general population to which we would like to extrapolate our findings, so we have an issue of selection bias here. D. Confounding is also a possibility – we controlled for smoking but there could be other unmeasured confounders.
In a country with a population of 6 million people, 60,000 deaths occurred during the previous year. These included 30,000 deaths from cholera in 100,000 people who were sick with cholera.
What was the cause-specific mortality rate from cholera during the previous year?
a. 5%
b. 10%
c. 50%
d. 5 per 1000
e. 10 per 1000
D. 5 per 1000
Cause-specific mortality rate per 1,000 population = # of deaths from that cause/# of people in the population x 1000 = 30,000 cholera deaths/6 million population x 1000 = 5 per 1000.
In a country with a population of 6 million people, 60,000 deaths occurred during the previous year. These included 30,000 deaths from cholera in 100,000 people who were sick with cholera.
What was the case-fatality from cholera in the previous year?
a. 1%
b. 5%
c. 10%
d. 30%
e. 50%
D. 30%. Case fatality rate = # dead from the disease/# with the disease
Which one of the following frustrations would you most likely expect in preparing to carry out cohort studies on animal disease?
a. Costly and time consuming, and plagued by the continual changing of the cohort.
b. Difficult time in selecting a comparison group or control population upon which to test your hypothesis.
c. Cohort populations are unchanging, and that no new individuals are introduced into the study population.
d. Data collected retrospectively is often incomplete, and plagued by high degrees of institutional bias.
e. Unable to get accurate estimates of incidence or prevalence of the disease using the cohort study technique.
A. Cohort studies, especially prospective cohort studies, tend to be more expensive, and theytake longer to conduct because you’re following forward in time. I would argue D is also anacceptable answer, as investigators using retrospective data have much less control over thecohort and less ability to be confident in the completeness of their data. Answers b and e tendto apply more to case-control studies.
One of your clients has a feedlot containing 15,000 cattle, 10,000 of which are susceptible. In a current outbreak of disease, 3,000 became sick and 300 died. The case fatality rate was:
a. 10%
b. 25%
c. 2%
d. 30%
e. 3%
A. CFR=the proportion of animals that die from a specified disease among all individuals diagnosed with the disease over a certain period of time
What study plan would be best to determine the effectiveness of a new vaccine in preventing disease in humans?
a. Case-control study.
b. Cohort study.
c. Prevalence study.
d. Morbidity study.
e. Retrospective study.
B. For an observational study, you want to compare outcomes among who was exposed, i.e.,vaccinated) and unexposed (non-vaccinated). For an experimental study, a randomized controltrial would be better!
A certain causal factor is thought to be associated with an extremely rare disease. What study plan would yield the best data with limited financial and human resources?
a. Prevalence study.
b. Case-control study.
c. Prevalence study.
d. Morbidity study.
e. Case evaluation study
B. Case control studies are better for rare diseases, because you don’t have to wait for cases of arare disease to accumulat
Match the following terms to their definitions:
A. A causal factor that is neither necessary nor sufficient, but increases the likelihood of disease, all other things being equal.
B. Any factor that must be present for the disease to occur.
C. Any factor or, more commonly a constellation of factors, that inevitably lead to the disease
i. Sufficient cause
ii. Necessary cause
iii. Contributing cause
A. contributing
B. Necessary
C. Sufficient
The measure most sensitive to extremes is:
a. Mean
b. Median
c. Mode
d. Sample
e. Inferential
A. The mean is most susceptible to outliers. That is why when we have non-normally distributedor skewed data, it is more appropriate to present the median when performing descriptivestatistics.
Generalizability is best assured by:
a. Representative nature
b. Randomness
c. Sample size
d. Precise manipulation
e. Statistical validity
A. Generalizability indicates how well your results are likely to apply to other populations. If your sample population is representative of other populations, then it is likely your results are generalizable.
Which of the following is NOT associated with a retrospective study?
a. Adaptable to conditions of low prevalence.
b. Less expensive than prospective.
c. Requires fewer personnel.
d. Takes longer to conduct.
e. Provides less accurate incidence rate.
D. If your data are retrospective (i.e., already collected), then you take out the time factor ofhaving to follow your population over time and accumulate cases with your desired outcome
An epidemic curve displays:
a. The population at risk versus the frequency of cases.
b. The frequency of cases versus the number of ill in the population.
c. The time of onset versus the population at risk.
d. The time of onset versus the frequency of incident cases.
e. The time of onset versus the number of individuals who are ill.
D. An “epidemic curve” shows the frequency of new cases over time based on the date of onsetof disease.